TABLE 3

Intermodality Versus Intramodality Management Change

Study	Radioligand	No. of patients	Overall change in management	Intermodality change^*	Intramodality change^*
Frilling et al. (27)	⁶⁸Ga-DOTATOC	52	31 (60%)	17 (55%)	14 (45%)
Froeling et al. (31)	⁶⁸Ga-DOTATOC	21	10 (48%)	4 (40%)	6 (60%)
Hofman et al. (32)	⁶⁸Ga-DOTATATE	59	34 (58%)	28 (82%)	6 (18%)
Has Simsek et al. (33)	⁶⁸Ga-DOTATATE	27	16 (59%)	15 (100%)^†	0 (0%)
Herrmann et al. (30)	⁶⁸Ga-DOTATATE	88	53 (60%)	52 (98%)	1 (2%)
Ilhan et al. (34)	⁶⁸Ga-DOTATATE	44	9 (20%)	5 (55%)	4 (45%)
Deppen et al. (22)	⁶⁸Ga-DOTATATE	78	28 (36%)	19 (68%)	9 (32%)

↵* Percentages are with respect to number of patients who had change in management.
↵† Conflicting data: 15 patients are listed with a change in management, even though the article text reports 16.